AROVELLA THERAPEUTICS LIMITED

Press Releases Arovella Therapeutics Limited

Equities

ALA

AU0000182784

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-05-20 am EDT			5-day change	1st Jan Change
0.115 ^AUD	0.00%		-8.00%	0.00%

Mar. 26	Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise	MT
Mar. 20	Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arovella Therapeutics focused on driving ALA-101 into the clinic	23-06-08	AQ
Arovella Therapeutics progresses patient-focused iNKT vision	23-05-08	AQ
Arovella Therapeutics : Quarterly Appendix 4C and Activities Report	22-07-28	PU
Arovella Therapeutics : Adopts WEF Framework For ESG Reporting	22-06-07	PU
Arovella Therapeutics : Proposed issue of securities - ALA	22-03-17	PU
Arovella Therapeutics : Application for quotation of securities - ALA	22-03-16	PU
Arovella Therapeutics : Update - Proposed issue of securities - ALA	22-02-28	PU
Aytu BioScience : Announces Regulatory Approval of ZolpiMist by Australian Therapeutic Goods Administration	20-07-31	AQ
Aytu BioScience : Announces Exclusive ZolpiMist License to Commercialize Aytu's Oral Spray Sleep Aid in South Korea	20-04-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW